Literature DB >> 30076182

Impact of FLT3-ITD length on prognosis of acute myeloid leukemia.

Song-Bai Liu1, Hao-Jie Dong2, Xie-Bing Bao3,4,5, Qiao-Cheng Qiu3,4,5, Hong-Zhi Li6, Hong-Jie Shen3,4,5, Zi-Xuan Ding3,4,5, Chao Wang3,4,5, Xiao-Ling Chu3,4,5, Jing-Qiu Yu3,4,5, Tao Tao3,4,5, Zheng Li3,4,5, Xiao-Wen Tang3,4,5, Su-Ning Chen3,4,5, De-Pei Wu3,4,5, Ling Li7, Sheng-Li Xue8,4,5.   

Abstract

Entities:  

Year:  2018        PMID： 30076182      PMCID： PMC6312017          DOI： 10.3324/haematol.2018.191809

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML).

Authors:  Rajko Kusec; Ozren Jaksic; Slobodanka Ostojic; Ika Kardum-Skelin; Radovan Vrhovac; Branimir Jaksic
Journal:  Blood       Date:  2006-07-01       Impact factor: 22.113

2.  Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia.

Authors:  Derek L Stirewalt; Kenneth J Kopecky; Soheil Meshinchi; Julia H Engel; Era L Pogosova-Agadjanyan; Jeremy Linsley; Marilyn L Slovak; Cheryl L Willman; Jerald P Radich
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

3.  Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivo.

Authors:  T Fischer; F H Heidel; P Arreba-Tutusaus; T S Mack; L Bullinger; T M Schnöder; A Polanetzki; S Weinert; A Ballaschk; Z Wang; A J Deshpande; S A Armstrong; K Döhner
Journal:  Leukemia       Date:  2015-10-21       Impact factor: 11.528

4.  Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.

Authors:  S Meshinchi; W G Woods; D L Stirewalt; D A Sweetser; J D Buckley; T K Tjoa; I D Bernstein; J P Radich
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

5.  Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.

Authors:  M Nakao; S Yokota; T Iwai; H Kaneko; S Horiike; K Kashima; Y Sonoda; T Fujimoto; S Misawa
Journal:  Leukemia       Date:  1996-12       Impact factor: 11.528

6.  The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

Authors:  Rosemary E Gale; Claire Green; Christopher Allen; Adam J Mead; Alan K Burnett; Robert K Hills; David C Linch
Journal:  Blood       Date:  2007-10-23       Impact factor: 22.113

7.  The structural basis for autoinhibition of FLT3 by the juxtamembrane domain.

Authors:  James Griffith; James Black; Carlos Faerman; Lora Swenson; Michael Wynn; Fan Lu; Judith Lippke; Kumkum Saxena
Journal:  Mol Cell       Date:  2004-01-30       Impact factor: 17.970

8.  Structural and numerical variation of FLT3/ITD in pediatric AML.

Authors:  Soheil Meshinchi; Derek L Stirewalt; Todd A Alonzo; Titus J Boggon; Robert B Gerbing; Jennifer L Rocnik; Beverly J Lange; D Gary Gilliland; Jerald P Radich
Journal:  Blood       Date:  2008-02-27       Impact factor: 22.113

Review 9.  FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions.

Authors:  Maria Larrosa-Garcia; Maria R Baer
Journal:  Mol Cancer Ther       Date:  2017-06       Impact factor: 6.261

10.  Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length.

Authors:  Y Kim; G D Lee; J Park; J-H Yoon; H-J Kim; W-S Min; M Kim
Journal:  Blood Cancer J       Date:  2015-08-14       Impact factor: 11.037
View more
  19 in total

1.  A novel prognostic scoring model for newly diagnosed FLT3-ITD-positive acute myeloid leukemia.

Authors:  Yi Zhang; Bi-De Zhao; Cheng-Cheng Wang; Yun-Gui Wang; Hua-Feng Wang; Jing-Han Wang; Li-Xia Liu; Feng Lou; Shan-Bo Cao; Xiao-Xia Hu; Ai-Jie Huang; Jian-Min Yang; Hai-Tao Meng; Wen-Juan Yu; Hong-Yan Tong; Jian-Min Wang; Jie Jin
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

2.  Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3-ITD-Positive AML.

Authors:  Megan E Zavorka Thomas; Xiyuan Lu; Zahra Talebi; Jae Yoon Jeon; Daelynn R Buelow; Alice A Gibson; Muhammad Erfan Uddin; Lindsey T Brinton; Julie Nguyen; Meghan Collins; Alessia Lodi; Shannon R Sweeney; Moray J Campbell; Douglas H Sweet; Alex Sparreboom; Rosa Lapalombella; Stefano Tiziani; Sharyn D Baker
Journal:  Mol Cancer Ther       Date:  2021-09-13       Impact factor: 6.261

3.  Adverse impact of a high allelic burden FLT3-ITD mutation on allogeneic hematopoietic stem cell transplantation in patients with cytogenetically normal AML.

Authors:  Li Wan; Shuqi Ding; Mimi Xu; Kangkang Lv; Yuanyuan Du; Depei Wu; Mingzhu Xu; Yuejun Liu
Journal:  Int J Hematol       Date:  2022-07-20       Impact factor: 2.319

4.  Impact of FLT3-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study.

Authors:  Elizabeth M Corley; Moaath K Mustafa Ali; Hanan Alharthy; Kathryn A F Kline; Danielle Sewell; Jennie Y Law; Seung Tae Lee; Sandrine Niyongere; Vu H Duong; Maria R Baer; Ashkan Emadi
Journal:  Biology (Basel)       Date:  2022-06-15

Review 5.  Gilteritinib: potent targeting of FLT3 mutations in AML.

Authors:  Mark Levis; Alexander E Perl
Journal:  Blood Adv       Date:  2020-03-24

6.  Impact of FLT3-ITD allele ratio and ITD length on therapeutic outcome in cytogenetically normal AML patients without NPM1 mutation.

Authors:  Fang Chen; Junya Sun; Changxin Yin; Jiaying Cheng; Jinle Ni; Ling Jiang; Qiang Wang; Guopan Yu; Yongqiang Wei; Xiaoli Liu; Jing Sun; Bing Z Carter; Xuejie Jiang
Journal:  Bone Marrow Transplant       Date:  2019-10-23       Impact factor: 5.483

Review 7.  Targeting FLT3 mutations in AML: review of current knowledge and evidence.

Authors:  Naval Daver; Richard F Schlenk; Nigel H Russell; Mark J Levis
Journal:  Leukemia       Date:  2019-01-16       Impact factor: 11.528

8.  The impact of FLT3 mutation clearance and treatment response after gilteritinib therapy on overall survival in patients with FLT3 mutation-positive relapsed/refractory acute myeloid leukemia.

Authors:  Jessica K Altman; Alexander E Perl; Jason E Hill; Matt Rosales; Erkut Bahceci; Mark J Levis
Journal:  Cancer Med       Date:  2020-12-19       Impact factor: 4.452

9.  Molecular characterisation of NPM1 and FLT3-ITD mutations in a central South African adult de novo acute myeloid leukaemia cohort.

Authors:  Jean F Kloppers; André de Kock; Johané Cronjé; Anne-Cecilia van Marle
Journal:  Afr J Lab Med       Date:  2021-06-30

10.  Nanopore Targeted Sequencing for Rapid Gene Mutations Detection in Acute Myeloid Leukemia.

Authors:  Cosimo Cumbo; Crescenzio Francesco Minervini; Paola Orsini; Luisa Anelli; Antonella Zagaria; Angela Minervini; Nicoletta Coccaro; Luciana Impera; Giuseppina Tota; Elisa Parciante; Maria Rosa Conserva; Orietta Spinelli; Alessandro Rambaldi; Giorgina Specchia; Francesco Albano
Journal:  Genes (Basel)       Date:  2019-12-09       Impact factor: 4.141
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.